Form 4 for ALHC Alignment Healthcare, Inc.
Accepted 2026-07-16 16:54:05 ET · period of report 2026-07-15 · accession 0001628280-26-048498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-16 16:54 | 2026-07-15 | ALHC | Maroney Dawn Christine | Pres | M - OptEx | $9.06 | +152.1K | 1.10M | +16% | +$1.38M |
| DT | 2026-07-16 16:54 | 2026-07-15 | ALHC | Maroney Dawn Christine | Pres | S - Sale+OE | $20.83 | -177.1K | 922.3K | -16% | -$3.69M |
| DT | 2026-07-16 16:54 | 2026-07-15 | ALHC | Maroney Dawn Christine | Pres | M - OptEx | $9.06 | -152.1K | 0 | -100% | -$1.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | M | A | 152,068 | $9.06 | 1,099,381 | D | — | — | (F1) Date of adoption of Rule 10b5-1 plan: 3/13/26 |
| 2 | Common | Common Stock | 2026-07-15 | S | D | 177,068 | $20.83 | 922,313 | D | — | — | (F1) Date of adoption of Rule 10b5-1 plan: 3/13/26 (F2) The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.29 to $21.14. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| 3 | Derivative | Options (Right to Buy) | 2026-07-15 | M | D | 152,068 | $9.06 | 0 | D | $9.06 · — to 2032-03-08 | 152,068 Common Stock | (F3) Options vested 25% on each of the first four anniversaries of the grant date (03/08/2022), subject to the reporting person's continued service to the Company as of the applicable vesting date. |